04307nam 2201297z- 450 991055762610332120220111(CKB)5400000000045154(oapen)https://directory.doabooks.org/handle/20.500.12854/76735(oapen)doab76735(EXLCZ)99540000000004515420202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierBacterial MeningitisEpidemiology and VaccinationBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (274 p.)3-0365-1807-X 3-0365-1808-8 This timely collection of expert papers draws attention to the global burden of meningitis and the challenges faced by the WHO's roadmap to defeat meningitis by 2030. The three main goals of the meningitis roadmap are to eliminate epidemics of bacterial meningitis, reduce cases and deaths from vaccine-preventable bacterial meningitis, and reduce disability and improve quality of life after meningitis of any cause. This book includes a wide range of original research and reviews on epidemiology and vaccination of bacterial meningitis that have direct relevance to advancing the goals of the roadmap.Bacterial MeningitisBiology, life sciencesbicsscResearch & information: generalbicsscAfricaantibiotic resistancebacterial meningitisburdenBurkina Fasocapsulecerebrospinal fluidchild mortalitychildrencomplementconjugate vaccineconjugate vaccinescorticosteroiddexamethasonedisabilityenterovirusepidemiologyepilepsyetiologic diagnosisfocal neurological deficitgenetic factorsglobalglobal healthglobal health estimatesgroup B streptococcigroup B streptococcusgroup B StreptococcusH. influenzaeHaemophilus influenzaehearing lossHiaHibhydrocephalusimpact of Hib conjugate vaccineinvasive bacterial infectionsinvasive meningococcal diseaseinvasive pneumococcal diseasemathematical modellingmeningitismeningococcal carriagemeningococcal groupmeningococcal urethritismeningococcusmeta-analysismodellingN. meningitidisn/anational reference laboratoryNeisseria meningitidisneonatal infectionsneonatal sepsisneurological sequelaeNigernongroupableNTHiPCV impactpneumococcal conjugate vaccinespneumococcal meningitispneumococcuspost-vaccine surveillancerapid diagnostic testS. agalactiaeS. pneumoniaeseizureserotype distributionserotypessocial and economic costsStreptococcus agalactiaeStreptococcus pneumoniaesurveillancesusceptibilityTBMtuberculosistuberculous meningitisvaccinevaccine impactWHO meningitis roadmapBiology, life sciencesResearch & information: generalStuart James Medt1309771Stuart James MothBOOK9910557626103321Bacterial Meningitis3029586UNINA